LEADER 03125 am 2200805 n 450 001 9910246752003321 005 20230713174344.0 010 $a2-85831-262-1 024 7 $a10.4000/books.pressesinalco.1274 035 $a(CKB)4100000001192398 035 $a(FrMaCLE)OB-pressesinalco-1274 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/47415 035 $a(PPN)223796417 035 $a(EXLCZ)994100000001192398 100 $a20171212j|||||||| ||| 0 101 0 $afre 135 $auu||||||m|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFantômes dans l'Extrême-Orient d'hier et d'aujourd'hui - Tome 1 /$fMarie Laureillard, Vincent Durand-Dastès 210 $aParis $cPresses de l?Inalco$d2017 215 $a1 online resource (563 p.) 311 $a2-85831-261-3 330 $aDémons et fantômes, gui ? , comptent parmi les figures les plus marquantes de la culture chinoise, et continuent de hanter encore de nos jours la société de la Chine et de ses voisins. En faisant appel aux taxinomies bouddhiques médiévales, aux livres de morale pré-modernes, aux débats philosophiques chinois ou japonais, comme aux ?uvres littéraires ou aux enquêtes de terrain, ce premier volume de Fantômes dans l?Extrême-Orient d?hier et d?aujourd?hui essaye de préciser les contours des êtres qui, en Asie orientale, se rapprochent le plus de nos « fantômes » et autres « ghosts ». 606 $aFolklore 606 $aLiterature 606 $aChine 606 $afantômes 606 $agui 606 $acroyance 606 $alittérature 610 $acroyance 610 $afantômes 610 $alittérature 610 $aChine 610 $agui 615 4$aFolklore 615 4$aLiterature 615 4$aChine 615 4$afantômes 615 4$agui 615 4$acroyance 615 4$alittérature 700 $aLaureillard$b Marie$01286653 701 $aDurand-Dastès$b Vincent$01286654 701 $aHan Yu ??$0656065 701 $a(???)$b Constantino Moretti$01300111 701 $a(???)$b Judith T. Zeitlin$01300112 701 $aBianchi$b Alice$01300113 701 $aChambon$b Michel$0921972 701 $aCruveillé$b Solange$01300114 701 $aDurand-Dastès$b Vincent$01286654 701 $aGoossaert$b Vincent$01075488 701 $aHuntington$b Rania$01300115 701 $aJunliang$b Pan$01200301 701 $aKraushaar$b Frank$01300116 701 $aLaureillard$b Marie$01286653 701 $aMacé$b François$01300117 701 $aPissin$b Annika$01300118 701 $aWang$b Frédéric$01300119 701 $aWang-Le$b Min Sook$01300120 701 $a???$b Kenny K. K. Ng$01300121 701 $a??$b Sandrine Marchand$01300122 701 $a???$b Vincent Durand-Dastès$01286654 801 0$bFR-FrMaCLE 906 $aBOOK 912 $a9910246752003321 996 $aFantômes dans l'Extrême-Orient d'hier et d'aujourd'hui - Tome 1$93399092 997 $aUNINA LEADER 07322nam 22017293u 450 001 9910139903203321 005 20230124183120.0 010 $a9786612250057 010 $a9781282250055 010 $a1282250051 010 $a9789240683716 010 $a9240683712 035 $a(CKB)1000000000804064 035 $a(EBL)456324 035 $a(OCoLC)312414630 035 $a(SSID)ssj0000306663 035 $a(PQKBManifestationID)12099017 035 $a(PQKBTitleCode)TC0000306663 035 $a(PQKBWorkID)10299140 035 $a(PQKB)11630015 035 $a(MiAaPQ)EBC456324 035 $a(Au-PeEL)EBL456324 035 $a(CaONFJC)MIL225005 035 $a(OCoLC)935270628 035 $a(EXLCZ)991000000000804064 100 $a20130418d2008|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 02$aA Practical Handbook on the Pharmacovigilance of Antimalarial Medicines 205 $a1st ed. 210 $aGeneva $cWorld Health Organization$d2008 215 $a1 online resource (175 p.) 300 $aDescription based upon print version of record. 311 08$a9789241547499 311 08$a9241547499 327 $aCOVER; TITLE; COPYRIGHT; TABLE OF CONTENTS; FOREWORD; PART 1: GUIDANCE DOCUMENT ON CHARACTERIZING AND COMMUNICATING UNCERTAINTY IN EXPOSURE ASSESSMENT; ACKNOWLEDGEMENTS; MEMBERS OF THE WHO/IPCS WORKING GROUP ON UNCERTAINTY IN EXPOSURE ASSESSMENT; LIST OF ACRONYMS AND ABBREVIATIONS; EXECUTIVE SUMMARY; 1. INTRODUCTION; 2. CONTEXT, CONCEPTS AND DEFINITIONS; 3. SOURCES OF UNCERTAINTY; 4. TIERED APPROACH TO UNCERTAINTY ANALYSIS; 5. UNCERTAINTY CHARACTERIZATION METHODS, INTERPRETATION AND USE; 6. COMMUNICATION; 7. CONCLUSIONS; 8. REFERENCES; GLOSSARY OF TERMS 327 $aANNEX 1: CASE-STUDY-QUALITATIVE UNCERTAINTY ANALYSISAppendix 1: Background for case-study; ANNEX 2: CASE-STUDY-QUANTITATIVE UNCERTAINTY ANALYSIS; PART 2: HALLMARKS OF DATA QUALITY IN CHEMICAL EXPOSURE ASSESSMENT; PREPARATION OF THE DOCUMENT; 1. INTRODUCTION; 2. WHAT DO WE MEAN BY "DATA" IN EXPOSURE ASSESSMENT?; 3. TOWARDS A BROADER DEFINITION OF QUALITY IN EXPOSURE ASSESSMENT: HALLMARKS OF DATA QUALITY; 4. FROM EXPOSURE DATA QUALITY TO THE QUALITY OF EXPOSURE ASSESSMENTS; 5. CONCLUSIONS; 6. REFERENCES; Back Cover 330 $a""The Handbook"" is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It is intended to be a source of practical advice for pharmacovigilance centres. It provides information on spontaneous reporting of adverse drug reactions as a complement to other WHO publications. In addition, it provides details on how to conduct cohort event monitoring, which is a method of active safety surveillance collecting information on all adverse events occurring after treatment. It also details how to perform causality assessment and signal identification, ap 517 $aPractical Handbook on the Pharmacovigilance of Antimalarial Medicines 606 $aAdverse Drug Reaction Reporting Systems 606 $aAntimalarials -- standards 606 $aAntimalarials 606 $aDrug Monitoring 606 $aDrug Utilization Review -- methods 606 $aPharmacoepidemiology -- methods 606 $aProduct Surveillance, Postmarketing 606 $aDrug monitoring$xSide effects 606 $aAntimalarials 606 $aDrug Monitoring 606 $aDrug Utilization Review 606 $aProduct Surveillance, Postmarketing 606 $aAdverse Drug Reaction Reporting Systems 606 $aPharmacoepidemiology 606 $aAntimalarials 606 $aMethods 606 $aUtilization Review 606 $aAntiprotozoal Agents 606 $aInvestigative Techniques 606 $aDrug Utilization 606 $aPharmacology 606 $aEpidemiology 606 $aEvaluation Studies as Topic 606 $aMonitoring, Physiologic 606 $aQuality of Health Care 606 $aQuality Assurance, Health Care 606 $aPublic Health 606 $aHealth Occupations 606 $aBiological Science Disciplines 606 $aAnalytical, Diagnostic and Therapeutic Techniques and Equipment 606 $aDiagnostic Techniques and Procedures 606 $aPharmacy Administration 606 $aAntiparasitic Agents 606 $aDisciplines and Occupations 606 $aMedicine 606 $aHealth Services Administration 606 $aNatural Science Disciplines 606 $aHealth Care Quality, Access, and Evaluation 606 $aOrganization and Administration 606 $aDiagnosis 606 $aAnti-Infective Agents 606 $aTherapeutic Uses 606 $aDelivery of Health Care 606 $aPharmacologic Actions 606 $aChemical Actions and Uses 606 $aChemicals and Drugs 606 $aPharmacy, Therapeutics, & Pharmacology$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 4$aAdverse Drug Reaction Reporting Systems. 615 4$aAntimalarials -- standards. 615 4$aAntimalarials. 615 4$aDrug Monitoring. 615 4$aDrug Utilization Review -- methods. 615 4$aPharmacoepidemiology -- methods. 615 4$aProduct Surveillance, Postmarketing. 615 0$aDrug monitoring$xSide effects. 615 0$aAntimalarials. 615 2$aDrug Monitoring. 615 2$aDrug Utilization Review. 615 2$aProduct Surveillance, Postmarketing. 615 2$aAdverse Drug Reaction Reporting Systems. 615 2$aPharmacoepidemiology. 615 2$aAntimalarials. 615 2$aMethods. 615 2$aUtilization Review. 615 2$aAntiprotozoal Agents. 615 2$aInvestigative Techniques. 615 2$aDrug Utilization. 615 2$aPharmacology. 615 2$aEpidemiology. 615 2$aEvaluation Studies as Topic. 615 2$aMonitoring, Physiologic. 615 2$aQuality of Health Care. 615 2$aQuality Assurance, Health Care. 615 2$aPublic Health. 615 2$aHealth Occupations. 615 2$aBiological Science Disciplines. 615 2$aAnalytical, Diagnostic and Therapeutic Techniques and Equipment 615 2$aDiagnostic Techniques and Procedures. 615 2$aPharmacy Administration. 615 2$aAntiparasitic Agents. 615 2$aDisciplines and Occupations 615 2$aMedicine. 615 2$aHealth Services Administration. 615 2$aNatural Science Disciplines. 615 2$aHealth Care Quality, Access, and Evaluation. 615 2$aOrganization and Administration. 615 2$aDiagnosis. 615 2$aAnti-Infective Agents. 615 2$aTherapeutic Uses. 615 2$aDelivery of Health Care. 615 2$aPharmacologic Actions. 615 2$aChemical Actions and Uses. 615 2$aChemicals and Drugs 615 7$aPharmacy, Therapeutics, & Pharmacology 615 7$aHealth & Biological Sciences 676 $a600 712 02$aWorld Health Organization, 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910139903203321 996 $aA Practical Handbook on the Pharmacovigilance of Antimalarial Medicines$92876288 997 $aUNINA